Please enable Javascript
The HemOnc Pulse
Meeting News
The HemOnc Pulse Live
Video Insights
In Print
Subscribe
Leukemia
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Lymphoma
Aggressive B-Cell Lymphoma
Hodgkin Lymphoma
Indolent B-Cell Lymphoma
Mantle Cell Lymphoma
T-Cell Lymphoma
MPN
Myelofibrosis
Polycythemia Vera
MDS
Myeloma
Transplantation & Cellular Therapy
teclistamab
Bispecific Antibody Treatment Leads to ‘Deep and Durable’ Responses in R/R MM
Cecilia Brown
Myeloma
|
November 22, 2022
Treatment with teclistamab, a T-cell–redirecting bispecific antibody, led to a “high rate of deep and durable...
Read More
Teclistamab Plus Daratumumab Shows Improved Clinical Efficacy in Pretreated Multiple Myeloma
Leah Sherwood
Myeloma
|
November 16, 2022
Among 37 evaluable patients, the ORR was 78%, and 27 patients had a VGPR or better...
Read More
Advertisement
Advertisement
Advertisement
Advertisement